White paper
To Cover or Not to Cover: GLP-1s
GLP-1 medicines were originally made to treat diabetes and have shown promise for other chronic conditions as well. Employers are understandably curious about these medicines, and many are struggling to decide if GLP-1s should be covered by employer-sponsored health benefits plans. In our white paper, we evaluate the pros and cons of covering these treatments and what the big picture looks like for employers and their members. Our discussion breaks down the topic into three parts:
- Part 1: Economic Implications
- Part 2: Employee Health and Productivity
- Part 3: Potential Drawbacks
Complete the form below to download our white paper.
